BPC-157

BPC-157 is a peptide that is a partial sequence of body protection compound that is derived from human gastric juice. Research shows that BPC-157 heightens the healing of many different types of tissue from tendon, muscle, and the nervous system. It can also increase blood flow back to injured sites, protect organs, prevent stomach ulcers and heal skin burns.
Currently, it is known that BPC-157 circulates systemically whether it is taken orally or injected subcutaneously. We also know that it is attracted to signalling molecules produced by injured tissues, yet the exact mechanism with which it heals is not known for certain and likely varies depending on the particular tissue and nature of the injury. Although the mechanism(s) of action are not fully understood, the scientific literature has identified some potential sources of this compound’s healing power, including its effect on the FAK-paxillin pathway (focal adhesion kinase – an enzyme present in injured tissues), nitric oxide, increased VEGF activity (vascular endothelial growth factor), and the upregulation of growth hormone receptors in injured tissues. VEGF specifically is responsible for angiogenesis, or the creation of new blood vessels and is the most likely mechanism by which BPC-157 is able to promote the healing of joint structures, tendons, and ligaments as it allows for an increased delivery of nutrients and various healing factors that are required for growth and repair. Most joint structures, ligaments, and tendons are composed primarily of different kinds of collagen and their healing can benefit from the increases in collagen production stimulated by BPC-157
ADDITIONAL BENEFITS OF BPC-157
This amazing compound also has many potential benefits outside of helping musculoskeletal repair and recovery. It is currently being researched for effects on neurological disorders, inflammation, and it has profound evidence for healing gut issues such as lesions caused by non-steroidal anti-inflammatory drugs (NSAIDS). This is especially interesting because, with the exception of opioids, the primary medication utilized for chronic joint pain and other such ailments are NSAIDS. This class of medications is proving to have more and more side effects with prolonged usage by the population as a whole. If BPC-157 does indeed prove effective for not only healing the issues that were once treated with NSAIDS and corticosteroids, but also reversing or mitigating damage caused by them, it would be a vast improvement over these outdated practices. One commonly prescribed corticosteroid named 6alpha-methylprednisolone is incredibly effective at reducing inflammation and pain, but it comes with a whole host of unwanted side effects including delayed healing of injured tissue. One study looked at the co-administration of BPC and 6alpha-methylprednisolone, and the results were astounding. BPC-157 induced faster muscle healing and full function restoration on a system and cellular level.